Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer by Age and Hormone Receptor Status: A Cost-Utility Analysis
William Leung, Giorgi Kvizhinadze, Nisha Nair, Tony Blakely
PLoS Medicine | PUBLIC LIBRARY SCIENCE | Published : 2016
Awarded by Health Research Council of New Zealand
WL, GK, NN & TB received funding from the Health Research Council of New Zealand (www.hrc.govt.nz) grant 10/248. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.